bf/NASDAQ:ADPT_icon.png

COM:ADAPTIVEBIOTECH

Adaptive Biotechnologies

  • Stock

Last Close

4.37

22/11 21:00

Market Cap

515.79M

Beta: -

Volume Today

2.30M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-42.83M
-
-46.45M
8.44%
-68.61M
47.71%
-146.23M
113.14%
-207.30M
41.76%
-200.37M
3.34%
-225.25M
12.42%
depreciation and amortization
5.80M
-
6M
3.52%
7.79M
29.85%
8.47M
8.74%
13.95M
64.70%
20.92M
49.93%
22.23M
6.27%
deferred income tax
637K
-
-1.24M
295.13%
-1.88M
51.33%
773K
141.10%
7.23M
835.71%
-60.92M
-
stock based compensation
7.01M
-
11.15M
59.07%
13.12M
17.71%
24.76M
88.67%
43.25M
74.67%
55.48M
28.27%
62.91M
13.39%
change in working capital
-5.47M
-
-1.72M
68.53%
254.93M
14,895.88%
-40.80M
116.00%
-56.82M
39.26%
-71.55M
25.93%
-46.18M
35.45%
accounts receivables
-2.43M
-
775K
131.93%
-7.82M
1,108.65%
2.61M
133.43%
-7.36M
381.75%
-22.65M
207.63%
2.03M
108.97%
inventory
-2.70M
-
-3.05M
12.94%
-1.23M
59.59%
-4.99M
305.69%
-5.20M
4.12%
817K
115.71%
-2.84M
447.37%
accounts payables
-1.84M
-
1.87M
201.25%
-2.43M
229.99%
5.25M
316.19%
5.23M
0.40%
7.11M
36.07%
-5.41M
176.04%
other working capital
1.49M
-
-1.32M
188.35%
266.41M
20,297.73%
-43.66M
116.39%
-49.48M
13.32%
-56.83M
14.85%
-39.97M
29.66%
other non cash items
6K
-
5K
16.67%
43K
760%
3.34M
7,660.47%
6.95M
108.27%
11.57M
66.50%
90.89M
685.43%
net cash provided by operating activities
-34.86M
-
-32.26M
7.46%
205.40M
736.73%
-149.68M
172.87%
-192.73M
28.76%
-183.94M
4.56%
-156.32M
15.02%
investments in property plant and equipment
-2.51M
-
-6.32M
152.11%
-11.20M
77.27%
-18.80M
67.88%
-61.75M
228.38%
-16.35M
73.52%
-10.70M
34.57%
acquisitions net
85K
-
470.50M
-
98.24M
79.12%
-181.21M
284.45%
-19.25M
89.37%
purchases of investments
-125.18M
-
-146.50M
17.03%
-884.22M
503.55%
-694.97M
21.40%
-316.54M
54.45%
-278.78M
11.93%
-429.56M
54.09%
sales maturities of investments
163.91M
-
153.54M
6.33%
413.72M
169.46%
596.72M
44.23%
559.50M
6.24%
298.03M
46.73%
569.90M
91.22%
other investing activites
122K
-
19K
84.43%
-470.50M
2,476,400%
-98.24M
79.12%
181.21M
284.45%
19.25M
89.37%
-1
100.00%
net cash used for investing activites
36.43M
-
736K
97.98%
-481.70M
65,547.96%
-117.04M
75.70%
181.21M
254.82%
2.90M
98.40%
129.65M
4,362.89%
debt repayment
-124.38M
-
common stock issued
320.85M
-
272.16M
15.18%
26.72M
90.18%
7.89M
70.47%
2.25M
71.55%
common stock repurchased
dividends paid
other financing activites
50.03M
-
1.25M
97.51%
-934K
174.84%
21.43M
2,394.11%
429K
98.00%
248.75M
57,883.68%
net cash used provided by financing activities
50.03M
-
1.25M
97.51%
319.92M
25,534.29%
293.59M
8.23%
27.15M
90.75%
132.26M
387.24%
2.25M
98.30%
effect of forex changes on cash
-201.32M
-
net change in cash
51.61M
-
-30.27M
158.66%
43.62M
244.09%
26.86M
38.43%
15.63M
41.81%
-48.77M
412.08%
-24.97M
48.81%
cash at beginning of period
33.76M
-
85.37M
152.88%
55.09M
35.46%
98.71M
79.18%
125.57M
27.21%
141.20M
12.45%
90.03M
36.24%
cash at end of period
85.37M
-
55.09M
35.46%
98.71M
79.18%
125.57M
27.21%
141.20M
12.45%
92.43M
34.54%
65.06M
29.61%
operating cash flow
-34.86M
-
-32.26M
7.46%
205.40M
736.73%
-149.68M
172.87%
-192.73M
28.76%
-183.94M
4.56%
-156.32M
15.02%
capital expenditure
-2.51M
-
-6.32M
152.11%
-11.20M
77.27%
-18.80M
67.88%
-61.75M
228.38%
-16.35M
73.52%
-10.70M
34.57%
free cash flow
-37.36M
-
-38.58M
3.25%
194.20M
603.42%
-168.49M
186.76%
-254.47M
51.04%
-200.29M
21.29%
-167.02M
16.61%

All numbers in (except ratios and percentages)